Showing results (51-60 of 66) with videos related to
Sort By:
Pageof 7
Journal of Hematology & Oncology|March 1, 2018
The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastomaClaudio Festuccia, Andrea Mancini, Alessandro Colapietro, et al.Cancers|October 24, 2019
The Brain Penetrating and Dual TORC1/TORC2 Inhibitor, RES529, Elicits Anti-Glioma Activity and Enhances the Therapeutic Effects of Anti-Angiogenetic Compounds in Preclinical Murine ModelsGiovanni Luca Gravina, Andrea Mancini, Alessandro Colapietro, et al.Frontiers in Cell and Developmental Biology|November 29, 2023
Lipid rafts mediate multilineage differentiation of human dental pulp-derived stem cells (DPSCs)Francesca Santilli, Jessica Fabrizi, Stefano Martellucci, et al.Pharmaceuticals (Basel, Switzerland)|November 27, 2021
Multiple Antitumor Molecular Mechanisms Are Activated by a Fully Synthetic and Stabilized Pharmaceutical Product Delivering the Active Compound Sulforaphane (SFX-01) in Preclinical Model of Human GlioblastomaAlessandro Colapietro, Alessandra Rossetti, Andrea Mancini, et al.Free Radical Biology & Medicine|November 25, 2017
KRIT1 loss-of-function induces a chronic Nrf2-mediated adaptive homeostasis that sensitizes cells to oxidative stress: Implication for Cerebral Cavernous Malformation diseaseCinzia Antognelli, Eliana Trapani, Simona Delle Monache, et al.Journal of Functional Morphology and Kinesiology|September 22, 2025
Impact of a 24-Week Workplace Physical Activity Program on Oxidative Stress Markers, Metabolic Health, and Physical Fitness: A Pilot Study in a Real-World Academic SettingGabriele Maisto, Maria Scatigna, Simona Delle Monache, et al.Chemmedchem|February 26, 2013
A combination strategy to inhibit Pim-1: synergism between noncompetitive and ATP-competitive inhibitorsMattia Mori, Cristina Tintori, Robert Selwyne Arul Christopher, et al.Oncotarget|June 1, 2018
UniPR1331, a small molecule targeting Eph/ephrin interaction, prolongs survival in glioblastoma and potentiates the effect of antiangiogenic therapy in miceClaudio Festuccia, Giovanni Luca Gravina, Carmine Giorgio, et al.Journal of Medicinal Chemistry|December 4, 2014
Combining X-ray crystallography and molecular modeling toward the optimization of pyrazolo[3,4-d]pyrimidines as potent c-Src inhibitors active in vivo against neuroblastomaCristina Tintori, Anna Lucia Fallacara, Marco Radi, et al.Cancers|March 16, 2019
The Small Molecule Ephrin Receptor Inhibitor, GLPG1790, Reduces Renewal Capabilities of Cancer Stem Cells, Showing Anti-Tumour Efficacy on Preclinical Glioblastoma ModelsGiovanni Luca Gravina, Andrea Mancini, Alessandro Colapietro, et al.Pageof 7